Qiangsheng Hu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Targeting ACSS2 disrupts metabolic-epigenetic crosstalk to restore apoptosis and temozolomide chemosensitivity in pancreatic neuroendocrine tumors.

Targeting ACSS2 disrupts metabolic-epigenetic crosstalk to restore apoptosis and temozolomide chemosensitivity in pancreatic neuroendocrine tumors.

Journal: Cancer letters

Published: January 19, 2026

GOT2-mediated suppression of CoQ10 biosynthesis drives ferroptosis with divergent effects in lung adenocarcinoma and atherosclerosis.

GOT2-mediated suppression of CoQ10 biosynthesis drives ferroptosis with divergent effects in lung adenocarcinoma and atherosclerosis.

Journal: Communications biology

Published: November 07, 2025

ACSS2/AATF Drives Soluble FasL-Mediated CD8+ T Cell Apoptosis in Pancreatic Neuroendocrine Tumors.

ACSS2/AATF Drives Soluble FasL-Mediated CD8+ T Cell Apoptosis in Pancreatic Neuroendocrine Tumors.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 15, 2025

Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cells.

Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cells.

Journal: Cancer letters

Published: January 28, 2025

Cis-Regulation of an m6A Eraser by an Insertion Variant Associated with Survival of Patients With Non-Small Cell Lung Carcinoma.

Cis-Regulation of an m6A Eraser by an Insertion Variant Associated with Survival of Patients With Non-Small Cell Lung Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 10, 2024

Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells.

Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells.

Journal: Cell death & disease

Published: May 01, 2024

Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species.

Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species.

Journal: Nature communications

Published: March 05, 2024

Cancer immunometabolism: advent, challenges, and perspective.

Cancer immunometabolism: advent, challenges, and perspective.

Journal: Molecular cancer

Published: December 26, 2023

Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1.

Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1.

Journal: Cell proliferation

Published: December 11, 2023

SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD.

SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD.

Journal: Cancer cell international

Published: October 24, 2022

Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.

Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.

Journal: Acta biochimica et biophysica Sinica

Published: August 19, 2022

ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells.

ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells.

Journal: Cancer research

Published: June 20, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026